The 4C5 Cell-Impermeable Anti-HSP90 Antibody with Anti-Cancer Activity
Author Information
Author(s): Sidera Katerina, El Hamidieh Avraam, Mamalaki Avgi, Patsavoudi Evangelia
Primary Institution: Hellenic Pasteur Institute
Hypothesis
Can a chimeric kappa light chain antibody be developed to inhibit cancer cell invasion and metastasis?
Conclusion
The chimeric 4C5 antibody significantly inhibits cancer cell invasion and reduces metastatic deposits in vivo.
Supporting Evidence
- The chimeric antibody retained the specificity and functional properties of the original antibody.
- In vitro assays showed a 46% reduction in cancer cell invasion.
- In vivo studies demonstrated a 38% reduction in metastatic deposits in the lungs of treated mice.
- The antibody was shown to be cell-impermeable, not affecting intracellular HSP90 function.
- Statistical analysis confirmed significant differences in wound closure between treated and control groups.
Takeaway
Scientists created a special antibody that can stop cancer cells from spreading without harming healthy cells.
Methodology
The study involved cloning, sequencing, and constructing a chimeric antibody, followed by in vitro and in vivo assays to test its efficacy.
Potential Biases
Potential bias in the interpretation of results due to the authors' affiliations and funding sources.
Limitations
The study primarily focuses on a single antibody and its effects, which may not be generalizable to other antibodies or cancer types.
Participant Demographics
SCID mice were used for in vivo experiments.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website